Hasnain Faheem

Director; Director, President & CEO · 3 filings · Latest: Aug 24, 2026

Gossamer Bio, Inc.

Kura Oncology, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
KURA	FAHEEM HASNAIN	—	Dec 9, 2025	Proposed Sale	$11.64	10,000	$116.4K	—	Dec 9 9:23 PM
KURA	FAHEEM HASNAIN	—	Mar 21, 2025	Proposed Sale	$7.85	30,000	$235.5K	—	Mar 21 8:21 PM